FY 1992 Financial Report
You can read this report in its original form here. MAPS' total income in FY 91-92 was $28,859.55. The following categories had no expenditures this fiscal year. Public Relations/Ads, Salaries, Grants, …
MDMA
Documents from the DEA Scheduling Hearing of MDMA, 1984-1988
1.Introduction to the Legal Record of the DEA’s 1984-1988 MDMA Scheduling Hearings DEA Announcement of proposed scheduling of MDMA as a Schedule I Drug, Federal Register, July 27, 1984 2. Before …
MDMA-Assisted Therapy Study Protocols
Phase 3 Trials: FDA Grants Breakthrough Therapy Designation for MDMA-Assisted Therapy for PTSD, Agrees on Special Protocol Assessment MAPS’ highest priority project is sponsoring Food and Drug Administration …